Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S(+)-ketamine for painless flexible fiberoptic bronchoscopy
ChiCTR2100043492Phase 4Recruiting
- Sponsor
- Hefei Second People's Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in airway diseases (3 arms), sponsored by Hefei Second People's Hospital. Primary endpoints: Richmond Agitation-Sedation Scale, Visual Analog Scale score and 8 more. Started Feb 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
airway diseases
Beyond the preview
Go deeper on ChiCTR2100043492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043492.